๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Dramatic decline in prostate-specific antigen by withdrawal of estramustine phosphate in hormone refractory prostate cancer

โœ Scribed by MIZUKI KOBAYASHI; HIROSHI KURAMOTO; JUNICHIRO OTA; NAOHIRO FUJIMOTO

Book ID
108977173
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
88 KB
Volume
13
Category
Article
ISSN
0919-8172

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Expression of prostate-specific antigen
Expression of prostate-specific antigen is transcriptionally regulated by genistein in prostate cancer cells
โœ Joanne N. Davis; Omer Kucuk; Fazlul H. Sarkar ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 260 KB

Prostate cancer is the second-leading cause of cancer-related deaths in men in the United States. Unfortunately, there is no effective therapy when prostate cancer becomes metastatic and refractory to conventional treatments. For this reason, the identification and exploration of new agents that red

The dynamics of prostate specific antige
The dynamics of prostate specific antigen in hormone refractory prostate carcinoma : An analysis of Cancer and Leukemia Group B Study 9181 of megestrol acetate
โœ Robin T. Vollmer; Nancy A. Dawson; Nicholas J. Vogelzang ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 113 KB ๐Ÿ‘ 2 views

## BACKGROUND. Although many physicians measure serum prostate specific antigen (PSA) during the follow-up of patients with hormone refractory prostate carcinoma (HRPC), little has been done to formalize the determination of how these serial values of PSA impact on prognosis. To understand HRPC fu